• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

越南顺化市Vi多糖伤寒疫苗的试验参与情况及疫苗可接受性

Trial participation and vaccine desirability for Vi polysaccharide typhoid fever vaccine in Hue City, Viet Nam.

作者信息

Kaljee Linda M, Pham Van, Son Nguyen Dinh, Hoa Nguyen Thai, Thiem Vu Dinh, Canh Do Gia, Thoa Le Thi Kim, Ali Mohammad, Ochiai Rion Leon, Danovaro-Holliday M Carolina, Acosta Camilo J, Stanton Bonita, Clemens John

机构信息

Department of Pediatrics, School of Medicine, University of Maryland, Baltimore MD, USA.

出版信息

Trop Med Int Health. 2007 Jan;12(1):25-36. doi: 10.1111/j.1365-3156.2006.01751.x.

DOI:10.1111/j.1365-3156.2006.01751.x
PMID:17207145
Abstract

OBJECTIVES

To identify demand for Vi typhoid fever vaccine for school-age children; obstacles and enabling factors for vaccine delivery; and socio-behavioural factors associated with trial participation and possible predictors of future vaccine acceptance, in Hue City, Viet Nam.

METHODS

Pre- and post-trial surveys of randomly selected households with children aged 6-17 years. Simple multinomial logistic analyses for ratios of relative risks (RRR) and significance on trial participation by demographics and variables related to typhoid fever, vaccination, and pre-trial experiences with information and consents. Multiple logistic regressions to assess differences in participation based on child's characteristics.

RESULTS

As many as 62.6% of households let all school age children participate, 10.2% let some participate, and 26.8% let none of their children participate in the trial. Factors associated with all children participating included past use of healthcare facilities (RRR, 0.45; 95% CI, 0.24-0.83), knowledge of vaccines (RRR, 0.17; 95% CI, 0.03-0.86), and perceived causes of typhoid fever (RRR, 0.90; 95% CI, 0.81-0.99). Factors associated with some children participating included utilization of healthcare facilities (RRR, 0.08; 95% CI, 0.01-0.66) and perceived severity of typhoid fever (RRR, 0.64; 95% CI 0.46-0.88). Participation was associated with satisfaction regarding pre-vaccination information and consent procedures. Children and adolescents were active decision-makers. Only 14 of 461 (2.2%) respondents would not use the Vi vaccine in the future for their child(ren).

CONCLUSIONS

Inter-related factors contribute to participation in a clinical vaccine trial, which may differ from desire to participate in a public health campaign. Educational campaigns need to be targeted to children and adolescents, and consideration for assent procedures for minors. Obtaining informed consent may affect trial participation within a social and political system unaccustomed to these procedures.

摘要

目的

确定越南顺化市学龄儿童对Vi伤寒疫苗的需求;疫苗交付的障碍和促成因素;以及与试验参与相关的社会行为因素和未来疫苗接受度的可能预测因素。

方法

对随机选择的有6至17岁儿童的家庭进行试验前和试验后调查。对相对风险率(RRR)以及按人口统计学和与伤寒、疫苗接种以及试验前信息和同意相关变量的试验参与显著性进行简单多项逻辑分析。进行多元逻辑回归以评估基于儿童特征的参与差异。

结果

多达62.6%的家庭让所有学龄儿童参与,10.2%的家庭让部分儿童参与,26.8%的家庭不让任何孩子参与试验。与所有儿童参与相关的因素包括过去使用医疗保健设施(RRR,0.45;95%置信区间,0.24 - 0.83)、疫苗知识(RRR,0.17;95%置信区间,0.03 - 0.86)以及伤寒热的感知病因(RRR,0.90;95%置信区间,0.81 - 0.99)。与部分儿童参与相关的因素包括医疗保健设施的使用(RRR,0.08;95%置信区间,0.01 - 0.66)以及伤寒热的感知严重程度(RRR,0.64;95%置信区间0.46 - 0.88)。参与与疫苗接种前信息和同意程序的满意度相关。儿童和青少年是积极的决策者。461名受访者中只有14名(2.2%)表示未来不会为其子女使用Vi疫苗。

结论

相互关联的因素促成了对临床疫苗试验的参与,这可能与参与公共卫生运动的意愿不同。教育活动需要针对儿童和青少年,并考虑未成年人的同意程序。在一个不习惯这些程序的社会和政治体系中,获得知情同意可能会影响试验参与。

相似文献

1
Trial participation and vaccine desirability for Vi polysaccharide typhoid fever vaccine in Hue City, Viet Nam.越南顺化市Vi多糖伤寒疫苗的试验参与情况及疫苗可接受性
Trop Med Int Health. 2007 Jan;12(1):25-36. doi: 10.1111/j.1365-3156.2006.01751.x.
2
The feasibility of a school-based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy.越南中部顺化市开展基于学校的Vi多糖疫苗大规模免疫运动的可行性:简化伤寒预防策略。
Southeast Asian J Trop Med Public Health. 2006 May;37(3):515-22.
3
Vaccine desirability during an effectiveness trial of the typhoid fever polysaccharide Vi vaccine in Kolkata India.在印度加尔各答进行的伤寒热多糖Vi疫苗有效性试验期间的疫苗可取性
Hum Vaccin. 2009 Sep;5(9):614-20. doi: 10.4161/hv.9313. Epub 2009 Sep 22.
4
A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design.一项多国整群随机对照有效性评估,旨在加速亚洲发展中国家引入Vi多糖伤寒疫苗:原理与设计
Trop Med Int Health. 2005 Dec;10(12):1219-28. doi: 10.1111/j.1365-3156.2005.01517.x.
5
Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.Vi 荚膜多糖伤寒疫苗在儿童中的效果:巴基斯坦卡拉奇的一项整群随机试验。
Vaccine. 2012 Aug 3;30(36):5389-95. doi: 10.1016/j.vaccine.2012.06.015. Epub 2012 Jun 18.
6
An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine.1999年中华人民共和国兴安县伤寒热暴发:Vi多糖伤寒疫苗现场效果评估
J Infect Dis. 2001 Jun 15;183(12):1775-80. doi: 10.1086/320729. Epub 2001 May 17.
7
Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China.中国农村居民对痢疾和伤寒的认知差异以及接种疫苗的意愿
Vaccine. 2006 Jan 30;24(5):561-71. doi: 10.1016/j.vaccine.2005.08.060. Epub 2005 Aug 30.
8
A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.印度Vi伤寒疫苗的整群随机有效性试验。
N Engl J Med. 2009 Jul 23;361(4):335-44. doi: 10.1056/NEJMoa0807521.
9
Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China.Vi多糖疫苗在中国西南部预防伤寒热的疗效试验。
Bull World Health Organ. 2001;79(7):625-31.
10
Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform.通过现有的基于学校的疫苗接种平台,在印度尼西亚雅加达北部的小学生中引入Vi多糖伤寒疫苗。
Public Health. 2006 Nov;120(11):1081-7. doi: 10.1016/j.puhe.2006.06.008. Epub 2006 Sep 26.

引用本文的文献

1
COVID-19 vaccination up-take in three districts of Nepal.尼泊尔三个地区的 COVID-19 疫苗接种情况。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2166321. doi: 10.1080/21645515.2023.2166321. Epub 2023 Jan 24.
2
The willingness to participate in biomedical research involving human beings in low- and middle-income countries: a systematic review.在中低收入国家参与涉及人类的生物医学研究的意愿:系统评价。
Trop Med Int Health. 2019 Mar;24(3):264-279. doi: 10.1111/tmi.13195. Epub 2019 Jan 8.
3
Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adults.
HIV 感染成人参与试验并接种新型结核病疫苗的意愿。
Public Health Action. 2013 Mar 21;3(1):31-7. doi: 10.5588/pha.12.0102.
4
Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India.口服霍乱疫苗试点示范项目期间的疫苗接种情况,印度奥里萨邦。
Hum Vaccin Immunother. 2014;10(10):2834-42. doi: 10.4161/21645515.2014.971655.
5
Formative investigation of acceptability of typhoid vaccine during a typhoid fever outbreak in Neno District, Malawi.在马拉维恩诺地区爆发伤寒期间,对伤寒疫苗可接受性进行形成性调查。
Am J Trop Med Hyg. 2014 Oct;91(4):729-37. doi: 10.4269/ajtmh.14-0067. Epub 2014 Jul 7.
6
Utilization and accessibility of healthcare on Pemba Island, Tanzania: implications for health outcomes and disease surveillance for typhoid fever.坦桑尼亚奔巴岛的医疗保健利用和可及性:对伤寒病卫生结果和疾病监测的影响。
Am J Trop Med Hyg. 2013 Jan;88(1):144-52. doi: 10.4269/ajtmh.2012.12-0288. Epub 2012 Dec 3.
7
Social and cultural determinants of oral cholera vaccine uptake in Zanzibar.桑给巴尔岛口服霍乱疫苗接种的社会文化决定因素。
Hum Vaccin Immunother. 2012 Sep;8(9):1223-9. doi: 10.4161/hv.20901. Epub 2012 Aug 16.
8
Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil.通过类比进行健康教育:为巴西流行地区钩虫疫苗的临床试验做准备。
PLoS Negl Trop Dis. 2010 Jul 20;4(7):e749. doi: 10.1371/journal.pntd.0000749.
9
Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance.桑给巴尔口服霍乱疫苗的使用:影响需求和接受度的社会经济及行为特征
BMC Public Health. 2009 Apr 7;9:99. doi: 10.1186/1471-2458-9-99.